Atara Biotherapeutics, Inc. and Pierre Fabre today announced an exclusive commercialization agreement for tabelecleucel (tab-cel®) in Europe, Middle East, Africa, and other select emerging markets for Epstein-Barr virus (EBV)-positive cancers.
Read moreCYNBIOSE AND HAWKCELL TEAM UP IN A STRATEGIC PARTNERSHIP FOR MRI SERVICES IN PRECLINICAL RESEARCH.
Read moreBE4S is a dedicated network of Experts and complementary competencies (preclinical R&D, management and business development) to bring your innovation to the success.
Read moreGTP Biologics is a subsidiary of the Fareva group specialized in the development and GMP production of biological molecules (antibodies, recombinant proteins, ADC).
Read moreCliniSciences commercialises reagents (antibodies, recombinants, ELISA kits, RNAi, cDNA clones, probes, PCR/qPCR reagents...) to diagnostic and research labs.
Read moreThis is a unique website which will require a more modern browser to work!
Please upgrade today!
